
Proximie
Proximie is a technology company.
Financial History
Proximie has raised $118.0M across 2 funding rounds.
Frequently Asked Questions
How much funding has Proximie raised?
Proximie has raised $118.0M in total across 2 funding rounds.

Proximie is a technology company.
Proximie has raised $118.0M across 2 funding rounds.
Proximie has raised $118.0M in total across 2 funding rounds.
Proximie has raised $118.0M in total across 2 funding rounds.
Proximie's investors include 2048 Ventures, Advent Life Sciences, B Capital Group, F-Prime Capital Partners, Global Ventures, GPO Fund, Jazz Venture Partners, Lazerow Ventures, Maverick Capital, Novastar Ventures, Questa Capital, Samsara BioCapital.
Proximie is a health technology company that builds a cloud-based platform and SDK serving as the operating system for intelligent operating rooms (ORs). It connects clinicians, medtech companies, and healthcare organizations by enabling real-time video, audio, data sharing, AI insights, and computer vision to streamline surgical workflows, support remote training, and improve patient outcomes.[1][2][3] The platform solves key challenges in surgery—such as limited access to expertise, unstructured OR data, and inefficient training—by digitizing procedures, creating a vast library of over 20,000 recorded surgeries (with 95% of sessions captured), and facilitating global telepresence in over 500 hospitals across 50+ countries.[2][4][5] With strong growth momentum, including $50 million in equity funding, 135 employees across Boston, London, and Beirut offices (as of 2022), and partnerships like Olympus in 2024, Proximie continues scaling through strategic integrations and data-driven innovations.[2][4][6]
Proximie was founded in 2016 by Nadine Hachach-Haram, a surgeon and CEO, who launched the platform to enable virtual presence in ORs using mixed reality (XR), digital audio-visual tools, and telepresence for clinicians, proctors, and medtech personnel.[2] Hachach-Haram's background as a practicing surgeon inspired the idea amid global disparities in surgical access, evolving from a tool for remote mentoring during the pandemic—used in places like Ethiopia and the US—to a comprehensive surgical intelligence system.[1][2][5] Early traction came from rapid adoption in tens of thousands of procedures, building a novel database of structured OR data, and expanding offices internationally, setting the stage for AI-enhanced analytics and partnerships.[2]
Proximie rides the wave of digital health transformation, particularly AI-driven surgical intelligence and telehealth, accelerated by pandemic needs for remote collaboration and now fueled by medtech demands for data interoperability.[1][2][4] Timing aligns with rising OR digitization—projected as essential for gold-standard training in 3-5 years—amid market forces like surgeon shortages, aging populations, and AI advancements in computer vision.[1][5] By creating structured surgical data ecosystems, Proximie influences the ecosystem as a connectivity hub, empowering OEMs, hospitals, and educators while fostering partnerships that standardize care and scale innovation globally.[3][4][7]
Proximie is poised to dominate as the OS for ORs, expanding via SDK adoptions, deeper AI analytics on its massive dataset, and more medtech alliances like Olympus to power every OR worldwide.[2][3][4] Trends in edge AI, data sovereignty, and hybrid tele-surgery will propel growth, potentially evolving its influence from training enabler to predictive outcomes platform amid regulatory tailwinds for secure health data sharing. This positions Proximie to turn fragmented ORs into efficient, insightful ecosystems, fulfilling its mission to make surgery universally accessible and effective.[1][7]
Proximie has raised $118.0M across 2 funding rounds. Most recently, it raised $80.0M Series C in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2022 | $80.0M Series C | 2048 Ventures, Advent Life Sciences, B Capital Group, F-Prime Capital Partners, Global Ventures, GPO Fund, Jazz Venture Partners, Lazerow Ventures, Maverick Capital, Novastar Ventures, Questa Capital, Samsara BioCapital, Amadeo Brenninkmeijer, Greg Schroy, Key Compton, Yumin Choi | |
| Apr 1, 2021 | $38.0M Series B | 2048 Ventures, B Capital Group, F-Prime Capital Partners, Global Ventures, GPO Fund, Jazz Venture Partners, Lazerow Ventures, Maverick Capital, Novastar Ventures, Questa Capital, Amadeo Brenninkmeijer, Greg Schroy, Key Compton, Yumin Choi |